Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oratec IPO Proceeds To Expand Marketing Of Thermal Spine/Joint Treatment

This article was originally published in The Gray Sheet

Executive Summary

Marketing activities for Oratec Interventions controlled thermal energy systems to treat spine and joint disorders will be expanded following a planned initial public offering, the firm says.

You may also be interested in...



Oratec Interventions

Initial public offering of 4 mil. shares at $14 each on April 5 grosses $56 mil. The Menlo Park, California firm markets the SpineCath intradiscal electrothermal therapy system and electrothermal arthroscopy system, and plans to use a portion of the IPO proceeds to expand marketing activities (1"The Gray Sheet" July 19, 1999, p. 11). Oratec shares trade on the Nasdaq exchange under the symbol "OTEC." Underwriters Merrill Lynch, J.P. Morgan and U.S. Bancorp Piper Jaffray hold an overallotment option for 600,000 additional shares

QUOTED. 27 November 2020. Agam Sharda.

The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel